Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome (SiVent)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Fresno, California, United States, 93701
- UCSF Fresno Community Regional Medical Center
-
Los Angeles, California, United States, 90033
- University of Southern California (LA County)
-
Sacramento, California, United States, 95817
- University of California Davis Medical Center
-
San Diego, California, United States, 92103
- UC San Diego Medical Center
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Christiana Care Health System
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical System Shock Trauma Center
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
-
Missouri
-
Saint Louis, Missouri, United States, 63130
- Washington University in St. Louis
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Medical Center
-
-
Texas
-
Austin, Texas, United States, 78701
- University Medical Center Brackenridge
-
Dallas, Texas, United States, 75390
- UT Southwestern (Parkland)
-
Houston, Texas, United States, 77030
- University of Texas Medical School, Houston
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Wisconsin
-
Wauwatosa, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following:
- Traumatic brain injury
- > 1 long bone fractures
- Shock on arrival in the Emergency Department (systolic BP < 90 mmHg)
- Lung contusion
- Receipt of > 6 units of blood
Exclusion Criteria:
- Inability to obtain consent from the patient or his/her legally authorized representative (LAR)
- Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention
- Age limitations per Institutional Review Board regulations
- Undergoing invasive mechanical ventilation for > 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective
- Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints
- Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations
- Prisoners, per Human Subjects regulations
- Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint
- Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol
- Burns > 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints
- Treating physicians being unwilling to use low VT ventilation strategy when ARDS is diagnosed as low VT ventilation is now considered standard of care for patients with ARDS.
- Moribund, not expected to survive 24 hours as this could affect the clinical course and cloud interpretation of the endpoints13. Treating physician's decision to use airway pressure release ventilation (APRV).
- Patient not expected to require mechanical ventilation > 24 hours (e.g., intubated for alcohol intoxication rather than pulmonary problem).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Sigh breaths
Sigh breaths consisting of a Tidal volume (VT) that produces a plateau pressure (Pplat) of 35 cmH2O (or 40 cmH2O in patients with BMIs > 35 or in patients with moderate or severe abdominal distension from ascites, blood and/or ileum, or prone patients).
The sigh breaths will be delivered once every 6 minutes, as part of usual invasive mechanical ventilation.
|
Sigh breaths delivered once every 6 minutes, as part of usual invasive mechanical ventilation.
|
|
No Intervention: Usual Care
Usual care, meaning that the treating physician will be free to treat the patient in any way he or she sees fit, including utilizing invasive mechanical ventilation as they wish.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ventilator-free Days (VFDs)
Time Frame: 28 days
|
Ventilator-free days (VFDs), defined as the number of days of unassisted breathing to day 28 without having to re-institute invasive ventilation.
Patients who died before day 28 were assigned 0 VFDs as were those transferred to a long-term care facility while ventilated.
|
28 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All-cause Mortality
Time Frame: 28 days
|
All-cause 28 day mortality
|
28 days
|
|
ICU-free Days
Time Frame: 28 days
|
Number of ICU-free days to day 28 after enrollment
|
28 days
|
|
Number of Participants With Complications of Treatment
Time Frame: 28 days
|
Specifically the number of participants experiencing pneumothorax, ventilator-associated pneumonia, hypotension requiring pressors, or pneumatoceles.
|
28 days
|
|
Discharge Status
Time Frame: 28 days
|
Percentage of patients discharged to extended care facilities, on mechanical ventilation, or to in-patient or home hospice
|
28 days
|
|
Number of Participants Requiring Oxygen Therapy at Discharge
Time Frame: 28 days
|
Number of Participants newly requiring continuous oxygen therapy at discharge.
|
28 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Richard Albert, MD, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1512M81688
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.